Novo Nordisk US Holdings, Inc. | Search

Accessibility help Skip to navigation Skip to content Skip to footer

Showing results for Novo Nordisk US Holdings, Inc.

Sort by

Viewing results 1‒25 of 23220

Disease control and prevention
Three health foundations tackle biggest disease threats in $300mn deal
...The foundation’s philanthropic firepower has surged thanks to sales of diabetes and weight loss drugs by Novo Nordisk, in which the foundation holds a controlling stake through its subsidiary Novo Holdings...
May 6, 2024
Novo Nordisk AS
Novo Nordisk chief seeks more deals to cement weight-loss lead amid ‘hype’
...But the companies do not have a history of protein manufacturing used by Novo Nordisk and its US rival Eli Lilly to make their diabetes and weight-loss products....
March 8, 2024
FT Live
US Pharma and Biotech Summit
Strategies for innovation, pricing and access
Thursday, 16 MayNew York, NY, USA
Novo Nordisk AS
Novo to use Ozempic and Wegovy windfall to invest $7bn a year by 2030
...Kasim Kutay, Novo Holdings chief executive and a Novo Nordisk board member, told the Financial Times that rising income from its 28 per cent stake in Novo Nordisk and other investments would give his fund...
February 12, 2024
Drugs research
Novo Nordisk and Eli Lilly set to face new challenger in weight-loss race
...Despite Novo Nordisk and Eli Lilly’s lead, Steensberg believed there was space for others to develop weight-loss products....
January 23, 2024
News in-depthNovo Nordisk AS
Novo Nordisk seeks to use obesity drug findings to prevent weight gain
...But she said if Novo Nordisk could develop such a treatment, it would be “ideal”....
December 5, 2023
Novo Nordisk AS
Novo Nordisk looks at flexible pricing for obesity drug
...He said Novo Nordisk was facing a “similar challenge” as some of the companies selling advanced therapies....
November 27, 2023
FT Live
US Decarbonization and Industrial Transition Summit
Securing the resources to build and finance America's clean energy future
Wednesday, 29 MayWashington, D.C., USA
Novo Nordisk AS
Novo Nordisk cuts price of weight loss drug Wegovy as competition heats up
...Novo Nordisk is lowering prices of its weight loss drug Wegovy as it boosts sales volumes and responds to higher competition from US rival Eli Lilly, leading to lower than expected quarterly revenue from...
May 2, 2024
News updates from March 5: China targets 5% GDP growth in 2024, Gold and Bitcoin hit record highs
Ozempic cuts risk of kidney-related illness, Novo Nordisk study shows
...Novo Nordisk plans to seek regulatory approval to expand the recommended uses of Ozempic in the US and EU in 2024, a move that could convince healthcare providers to pay more for the drugs....
March 5, 2024
Novo Nordisk AS
Novo Nordisk strikes $11bn deal to expand production of weight loss drug
...Novo Holdings owns 28 per cent of the shares in Novo Nordisk but has 77 per cent of the voting rights....
February 5, 2024
News updates from February 5: King Charles diagnosed with cancer, McDonald’s blames war on weak sales
Novo Holdings agrees to buy Catalent in $16.5bn deal
...Novo Holdings, the controlling shareholder in Novo Nordisk, has signed a $16.5bn deal to acquire US-based medicines manufacturer Catalent, in a deal that will bolster the Danish drugmaker’s supply chain....
February 5, 2024
News in-depthEli Lilly & Co
Eli Lilly races to boost capacity as it rolls out rival to Novo Nordisk weight-loss drug
...However, the plants will not enable Novo Nordisk to ramp up production until 2026....
March 5, 2024
Eli Lilly & Co
Eli Lilly calls for scrutiny of rival Novo Nordisk’s deal to expand production of weight-loss drug
...“Once it is complete, which we anticipate around the end of 2024, Novo Nordisk will honour all existing contracts,” the company told the FT on Tuesday. Novo Holdings declined to comment....
February 6, 2024
LexHelen Thomas
The Lex Newsletter: Living in an Ozempic world Premium content
...Ozempic” takes, referring to the diabetes and obesity medicine produced by Eli Lilly’s rival in the category, Novo Nordisk....
March 15, 2024
Novo Nordisk AS
Novo Nordisk ‘surprised’ by high European demand for weight-loss drugs
...Danish drugmaker Novo Nordisk has been “surprised” by the readiness of European consumers to pay for weight-loss drugs from their own pockets, as the region’s largest company invests in new supply to meet...
February 4, 2024
Novo Nordisk AS
Novo Nordisk shares hit record high as weight-loss drugs power profits
...Eli Lilly, maker of Mounjaro and the recently approved Zepbound, and Novo Nordisk have so far dominated the sector....
January 31, 2024
FT Live
Funding Biopharma Innovation
Strategies for investing in drug development and commercialization
Wednesday, 26 June345 Park Avenue South, New York, NY, USA
News in-depthDrugs research
The race to develop the next generation of weight-loss drugs
...“We have a very nice palette across the range of efficacy, safety and scalability and that allows us to be in the driver’s seat,” said Martin Holst Lange, Novo Nordisk’s vice-president of development....
April 1, 2024
The Big Read
FT Person of the Year: Lars Fruergaard Jørgensen of Novo Nordisk
...Novo Holdings, which manages the foundation’s wealth, has 77 per cent of the voting rights of Novo Nordisk....
December 19, 2023
News updates from May 3: US adds 175,000 jobs in April; Trump Media auditor barred
Risers and fallers in Europe
...Novo Nordisk: Shares in the Danish pharmaceutical company dropped 5 per cent after its US rival Amgen announced encouraging trial data on its experimental obesity drug MariTide....
May 3, 2024
Drugs research
Viking Therapeutics shares more than double on ‘statistically significant’ weight-loss trial results
...US biotech Viking Therapeutics’ shares more than doubled after trial data for the company’s weight-loss drug outperformed existing treatments from drugmakers Novo Nordisk and Eli Lilly....
February 27, 2024
Novo Nordisk AS
Novo Nordisk signs deals worth up to $1bn with US biotechs in race for obesity drugs
...Novo Nordisk has signed deals worth up to $1bn with US biotech start-ups developing treatments for obesity and other cardiometabolic diseases, as the Wegovy manufacturer seeks to stay ahead in a major new...
January 4, 2024
News updates from November 6: Gaza death toll surpasses 10,000, Trump’s New York fraud trial starts
Novo Nordisk warns EU that new rules will push it to expand faster in US
...Read more about Novo Nordisk here....
November 5, 2023
Moral Money
The societal side effects of weight-loss drugs Premium content
...The US Food and Drug Administration says there is a shortage of Novo Nordisk’s and Eli Lilly’s diabetes drugs, while Belgium has banned the off-label use of Novo Nordisk’s diabetes drug for obesity treatments...
March 13, 2024
Novo Nordisk AS
Novo Nordisk’s sales of weight loss drugs soar
...But Novo Nordisk is likely to face increased competition from Eli Lilly, if the US rival’s Mounjaro diabetes drug is also approved for the treatment of obesity....
November 2, 2023
News updates from May 2: Apple’s revenue hit by falling China sales; Gazprom plunges to $7bn loss
European stocks slip after Federal Reserve says US interest rates will remain higher
...Novo Nordisk, the maker of weight loss drugs Ozempic and Wegovy, fell 2.8 per cent despite beating profit forecasts, after the group warned it would face “continued periodic supply constraints”....
May 2, 2024
News in-depthNovo Nordisk AS
How anti-obesity drugs built the world’s largest charitable foundation
...The Novo Nordisk Foundation is the controlling shareholder of Danish drugmaker Novo Nordisk, currently Europe’s most valuable company thanks to soaring sales of weight loss and diabetes drugs Wegovy and...
December 26, 2023

Previous pagePage 1 of 929Next page